Status:
UNKNOWN
The Role of Quantitative Measures on Dual-energy CT in the Prediction of Colorectal Adenocarcinoma
Lead Sponsor:
Hôpital Fribourgeois
Conditions:
Colorectal Adenocarcinoma
Eligibility:
All Genders
20-80 years
Brief Summary
To demonstrate the potential role of dual-energy computed tomography (DECT) by iodine maps data, aimed at discriminating colon cancer from colon wall pseudo-thickening.
Detailed Description
Prospectively, 50 consecutive patients with pathology-proved colorectal tumor (detected by optical colonoscopy) who undergo routine thoraco-abdominal DECT for initial staging in the Department of Radi...
Eligibility Criteria
Inclusion
- . pathology-proved colorectal tumor
Exclusion
- BMI above 30 kg/m2
- renal insufficiency (estimated glomerular filtration rate \< 30 ml/min),
- allergy to iodinated contrast, and a
- known history of previous abdominal radiotherapy
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04430127
Start Date
April 1 2020
End Date
December 31 2022
Last Update
August 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sonaz Malekzadeh
Fribourg, Switzerland, 1708